BREATHE 2 Clinic Stop-Smoking Treatment Outreach Study
NCT05683821
Behavior, Cigarette Smoking
Madison, Wisconsin, United States
View Trial DetailsNCT Number: NCT04826549
The main objective of this study is to determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples, as well as assessing its agreement with the Vitalograph BreathCO monitor. Validating the precision and accuracy of the iCOquit Smokerlyzer could establish an additional, less expensive, reliable method for determining smoking status in tobacco research. Additionally, the portability of the device would allow for remote biochemical verification of smoking status, thus enlarging the number of participants that can be included in intervention studies.
Looking for future studies?
Notify Me21 year–65 year
All sexes
Observational
Rose Research Center, Charlotte, North Carolina, United States
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
-
Time frame: Baseline
Determine the accuracy and precision of the iCOquit Smokerlyzer as compared with the gold standard of COHb levels measured in venous plasma samples.
Time frame: Baseline
Comparing the CO values from the eCO Monitor and the Vitalograph BreathCO monitor.
Time frame: Daily for 5 days
Validate a new mobile app called eResearch through specific functionality testing by study participants.
Rose Research Center, LLC
Industry
Acronym: COCO
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05683821
Behavior, Cigarette Smoking
Madison, Wisconsin, United States
View Trial DetailsNCT03083353
Behavior, Chemically-Induced Disorders
Austin, Texas, United States
View Trial DetailsNCT03113136
Behavior, Chemically-Induced Disorders
Columbus, Ohio, United States
View Trial DetailsNCT03496077
Behavior, Chemically-Induced Disorders
Farmington, Connecticut, United States
View Trial Details